BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2021
View Archived Issues
Proof-of-concept study of two targeted phage-based vaccination approaches against SARS-CoV-2
Read More
Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors
Read More
New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical
Read More
LegoChem Biosciences descibes new antibody-drug conjugates
Read More
Reyoung divulges new autophagy inhibitors
Read More
180 Life Sciences selects lead synthetic CBD analogue for inflammation and pain
Read More
MindMed begins phase I study of DMT
Read More
New SERD discovered by dynamics simulation shows promise for breast cancer therapy
Read More
COVIDITY-001 study of SCOV-1 and SCOV-2 vaccine candidates approved in South Africa
Read More
Vaxart's oral norovirus vaccine boosts immune responses in previously vaccinated subjects
Read More
Initial data reported from phase Ib study of ATRC-101
Read More
AUG-3387 binds and neutralizes the SARS-CoV-2 Delta variant in vitro
Read More
KV-998083 effective in models of thrombosis and vascular leakage
Read More
Positive phase II data for LB-1148 in patients undergoing gastrointestinal surgery
Read More
In vivo gene editing alleviates amyloid pathologies
Read More
FDA clears IND application for DCR-AUD
Read More
Enrollment opens in phase IIa study of MT-3921 for acute traumatic cervical spinal cord injury
Read More
S2X259, novel human MAb with potential to overcome the emergence of SARS-CoV-2 variants
Read More
Eli Lilly presents SAD and MAD data for LY-3372689 in healthy volunteers
Read More
JNJ-78278343 enters phase I trial for advanced prostate cancer
Read More
TVB-2640 shows promising efficacy in phase II FASCINATE-1 study in patients with NASH
Read More
HA-121-28 studied in phase II for medullary thyroid carcinoma
Read More
SymBio opens phase IIa study of brincidofovir in subjects with adenovirus infection
Read More